Zebra
Senior Member
- Messages
- 1,091
- Location
- Northern California
Hi, Comrades,
If you suffer from upper or lower GI dysmotility, I hope you will check out this post.
The Mayo Clinic has identified a distinct autoimmune form of GI dysmotility and offers a panel of antibody testing to confirm the diagnosis.
Presumably you and your GI doctor would go through all the GI medical tests necessary to identify upper or lower GI dysmotility and then you would probably have to bring the Mayo Clinic GI Dysmotility antibody blood test to your doctor's attention, as it does not appear to be well-known condition.
Why is it worth asking for? Because instead of just symptom support, you would qualify for immunotherapy to address the root of the problem.
Here's some info from the Mayo Clinic and a link to the aforementioned testing.
LINK TO TEST: https://www.mayocliniclabs.com/test-catalog/overview/92120
If you suffer from upper or lower GI dysmotility, I hope you will check out this post.
The Mayo Clinic has identified a distinct autoimmune form of GI dysmotility and offers a panel of antibody testing to confirm the diagnosis.
Presumably you and your GI doctor would go through all the GI medical tests necessary to identify upper or lower GI dysmotility and then you would probably have to bring the Mayo Clinic GI Dysmotility antibody blood test to your doctor's attention, as it does not appear to be well-known condition.
Why is it worth asking for? Because instead of just symptom support, you would qualify for immunotherapy to address the root of the problem.
Here's some info from the Mayo Clinic and a link to the aforementioned testing.
Improving patient outcomes with targeted antibody testing
Autoimmune gastrointestinal dysmotility (AGID) is a clinical and limited manifestation of autoimmune dysautonomia typically associated with syncope, neuropathy, and sweating problems, but may also involve chronic gastrointestinal dysmotility.
Identifying gastrointestinal dysmotility as autoimmune-mediated is extremely important because patients treated with immunotherapy can see a dramatic improvement — going from persistent nausea, vomiting, and weight loss to feeling normal within a few weeks. Our algorithmic approach to AGID testing uses multiple methodologies to identify antibodies associated with the illness. Test results can direct a search for an underlying cancer and guide treatment selection.
Useful for investigating unexplained weight loss, early satiety, anorexia, nausea, vomiting, constipation, or diarrhea in a patient with past or family history of cancer or autoimmunity.
Can direct a focused search for cancer.
Can help differentiate AGID from the effects of chemotherapy.
LINK TO TEST: https://www.mayocliniclabs.com/test-catalog/overview/92120
Last edited: